Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Grifols Sa Institute

02 2Pfizer Europe Ma Eeig

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Fostamatinib Disodium Hexahydrate

Brand Name : Tavlesse

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2020-06-03

Application Number : 1191405001

Regulatory Info : Authorized

Registration Country : Spain

blank

02

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Fostamatinib Disodium Hexahydrate

Brand Name : Tavlesse

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date : 2020-06-03

Application Number : 1191405002

Regulatory Info : Authorized

Registration Country : Spain

blank

03

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Marstacimab

Brand Name : Hympavzi

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 18/11/2024

Application Number : 20231009000225

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Marstacimab

Brand Name : Hympavzi

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 18/11/2024

Application Number : 20231009000218

Regulatory Info : Approved

Registration Country : Sweden

blank